Score 76
In the landmark STEP 1 trial (Once-Weekly Semaglutide in Adults with Overweight or Obesity, Wilding and colleagues, New England Journal of Medicine , 2021), 1,961 adults who took weekly semaglutide (2.4 mg) plus lifestyle support lost a mean of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo, and 86% achieved at least 5% weight loss
An FSA user paying with a health spending card receives identical service and medication as someone using an HSA or personal funds
Physical function: 16 weeks of GlyNAC supplementation significantly increased gait speed in older adults
Glutathione production in cells declines naturally at an average rate of 10% per decade after age 20
[] The 1930s introduced 2,4-dinitrophenol (DNP), an effective metabolic stimulant withdrawn due to fatal toxicity